- Home
- SNDX vs ADEA Comparison
SNDX vs ADEA Comparison
Compare SNDX & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- ADEA
- Stock Information
- Founded
- SNDX 2005
- ADEA 1990
- Country
- SNDX United States
- ADEA United States
- Employees
- SNDX N/A
- ADEA N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- ADEA Computer Software: Prepackaged Software
- Sector
- SNDX Health Care
- ADEA Technology
- Exchange
- SNDX Nasdaq
- ADEA Nasdaq
- Market Cap
- SNDX 1.4B
- ADEA 1.3B
- IPO Year
- SNDX 2016
- ADEA N/A
- Fundamental
- Price
- SNDX $13.63
- ADEA $14.61
- Analyst Decision
- SNDX Strong Buy
- ADEA Strong Buy
- Analyst Count
- SNDX 11
- ADEA 2
- Target Price
- SNDX $37.64
- ADEA $17.00
- AVG Volume (30 Days)
- SNDX 1.9M
- ADEA 549.1K
- Earning Date
- SNDX 11-05-2024
- ADEA 11-07-2024
- Dividend Yield
- SNDX N/A
- ADEA 1.39%
- EPS Growth
- SNDX N/A
- ADEA N/A
- EPS
- SNDX N/A
- ADEA 0.37
- Revenue
- SNDX $16,000,000.00
- ADEA $343,723,000.00
- Revenue This Year
- SNDX N/A
- ADEA N/A
- Revenue Next Year
- SNDX N/A
- ADEA $8.51
- P/E Ratio
- SNDX N/A
- ADEA $38.96
- Revenue Growth
- SNDX N/A
- ADEA N/A
- 52 Week Low
- SNDX $13.26
- ADEA $9.68
- 52 Week High
- SNDX $25.34
- ADEA $14.75
- Technical
- Relative Strength Index (RSI)
- SNDX 30.64
- ADEA 68.21
- Support Level
- SNDX $13.36
- ADEA $14.20
- Resistance Level
- SNDX $14.18
- ADEA $14.75
- Average True Range (ATR)
- SNDX 0.81
- ADEA 0.49
- MACD
- SNDX -0.18
- ADEA 0.17
- Stochastic Oscillator
- SNDX 11.32
- ADEA 90.60
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property Licensing (IP). In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.